Mamu-A*01/Kb transgenic and MHC Class I knockout mice as a tool for HIV vaccine development

Jinliang Li, Tumul Srivastava, Ravindra Rawal, Edwin Manuel, Donna Isbell, Walter Tsark, Corinna La Rosa, Zhongde Wang, Zhongqi Li, Peter A Barry, Katharine D. Hagen, Jeffrey Longmate, Don J. Diamond

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

We have developed a murine model expressing the rhesus macaque (RM) Mamu-A*01 MHC allele to characterize immune responses and vaccines based on antigens of importance to human disease processes. Towards that goal, transgenic (Tg) mice expressing chimeric RM (α1 and α2 Mamu-A*01 domains) and murine (α3, transmembrane, and cytoplasmic H-2Kb domains) MHC Class I molecules were derived by transgenesis of the H-2KbDb double MHC Class I knockout strain. After immunization of Mamu-A*01/Kb Tg mice with rVV-SIVGag-Pol, the mice generated CD8+ T-cell IFN-γ responses to several known Mamu-A*01 restricted epitopes from the SIV Gag and Pol antigen sequence. Fusion peptides of highly recognized CTL epitopes from SIV Pol and Gag and a strong T-help epitope were shown to be immunogenic and capable of limiting an rVV-SIVGag-Pol challenge. Mamu-A*01/Kb Tg mice provide a model system to study the Mamu-A*01 restricted T-cell response for various infectious diseases which are applicable to a study in RM.

Original languageEnglish (US)
Pages (from-to)16-28
Number of pages13
JournalVirology
Volume387
Issue number1
DOIs
StatePublished - Apr 25 2009

Fingerprint

AIDS Vaccines
Macaca mulatta
Knockout Mice
Transgenic Mice
Epitopes
T-Lymphocytes
gag Gene Products
Gene Transfer Techniques
Communicable Diseases
Immunization
Vaccines
Alleles
Antigens
Peptides

Keywords

  • Cellular immunity
  • Mamu A*01
  • Peptide vaccine
  • Poxvirus challenge
  • SIV
  • Transgenic mouse model

ASJC Scopus subject areas

  • Virology

Cite this

Li, J., Srivastava, T., Rawal, R., Manuel, E., Isbell, D., Tsark, W., ... Diamond, D. J. (2009). Mamu-A*01/Kb transgenic and MHC Class I knockout mice as a tool for HIV vaccine development. Virology, 387(1), 16-28. https://doi.org/10.1016/j.virol.2009.01.041

Mamu-A*01/Kb transgenic and MHC Class I knockout mice as a tool for HIV vaccine development. / Li, Jinliang; Srivastava, Tumul; Rawal, Ravindra; Manuel, Edwin; Isbell, Donna; Tsark, Walter; La Rosa, Corinna; Wang, Zhongde; Li, Zhongqi; Barry, Peter A; Hagen, Katharine D.; Longmate, Jeffrey; Diamond, Don J.

In: Virology, Vol. 387, No. 1, 25.04.2009, p. 16-28.

Research output: Contribution to journalArticle

Li, J, Srivastava, T, Rawal, R, Manuel, E, Isbell, D, Tsark, W, La Rosa, C, Wang, Z, Li, Z, Barry, PA, Hagen, KD, Longmate, J & Diamond, DJ 2009, 'Mamu-A*01/Kb transgenic and MHC Class I knockout mice as a tool for HIV vaccine development', Virology, vol. 387, no. 1, pp. 16-28. https://doi.org/10.1016/j.virol.2009.01.041
Li, Jinliang ; Srivastava, Tumul ; Rawal, Ravindra ; Manuel, Edwin ; Isbell, Donna ; Tsark, Walter ; La Rosa, Corinna ; Wang, Zhongde ; Li, Zhongqi ; Barry, Peter A ; Hagen, Katharine D. ; Longmate, Jeffrey ; Diamond, Don J. / Mamu-A*01/Kb transgenic and MHC Class I knockout mice as a tool for HIV vaccine development. In: Virology. 2009 ; Vol. 387, No. 1. pp. 16-28.
@article{2b52d2c5252d46989ed5b41dce69513a,
title = "Mamu-A*01/Kb transgenic and MHC Class I knockout mice as a tool for HIV vaccine development",
abstract = "We have developed a murine model expressing the rhesus macaque (RM) Mamu-A*01 MHC allele to characterize immune responses and vaccines based on antigens of importance to human disease processes. Towards that goal, transgenic (Tg) mice expressing chimeric RM (α1 and α2 Mamu-A*01 domains) and murine (α3, transmembrane, and cytoplasmic H-2Kb domains) MHC Class I molecules were derived by transgenesis of the H-2KbDb double MHC Class I knockout strain. After immunization of Mamu-A*01/Kb Tg mice with rVV-SIVGag-Pol, the mice generated CD8+ T-cell IFN-γ responses to several known Mamu-A*01 restricted epitopes from the SIV Gag and Pol antigen sequence. Fusion peptides of highly recognized CTL epitopes from SIV Pol and Gag and a strong T-help epitope were shown to be immunogenic and capable of limiting an rVV-SIVGag-Pol challenge. Mamu-A*01/Kb Tg mice provide a model system to study the Mamu-A*01 restricted T-cell response for various infectious diseases which are applicable to a study in RM.",
keywords = "Cellular immunity, Mamu A*01, Peptide vaccine, Poxvirus challenge, SIV, Transgenic mouse model",
author = "Jinliang Li and Tumul Srivastava and Ravindra Rawal and Edwin Manuel and Donna Isbell and Walter Tsark and {La Rosa}, Corinna and Zhongde Wang and Zhongqi Li and Barry, {Peter A} and Hagen, {Katharine D.} and Jeffrey Longmate and Diamond, {Don J.}",
year = "2009",
month = "4",
day = "25",
doi = "10.1016/j.virol.2009.01.041",
language = "English (US)",
volume = "387",
pages = "16--28",
journal = "Virology",
issn = "0042-6822",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Mamu-A*01/Kb transgenic and MHC Class I knockout mice as a tool for HIV vaccine development

AU - Li, Jinliang

AU - Srivastava, Tumul

AU - Rawal, Ravindra

AU - Manuel, Edwin

AU - Isbell, Donna

AU - Tsark, Walter

AU - La Rosa, Corinna

AU - Wang, Zhongde

AU - Li, Zhongqi

AU - Barry, Peter A

AU - Hagen, Katharine D.

AU - Longmate, Jeffrey

AU - Diamond, Don J.

PY - 2009/4/25

Y1 - 2009/4/25

N2 - We have developed a murine model expressing the rhesus macaque (RM) Mamu-A*01 MHC allele to characterize immune responses and vaccines based on antigens of importance to human disease processes. Towards that goal, transgenic (Tg) mice expressing chimeric RM (α1 and α2 Mamu-A*01 domains) and murine (α3, transmembrane, and cytoplasmic H-2Kb domains) MHC Class I molecules were derived by transgenesis of the H-2KbDb double MHC Class I knockout strain. After immunization of Mamu-A*01/Kb Tg mice with rVV-SIVGag-Pol, the mice generated CD8+ T-cell IFN-γ responses to several known Mamu-A*01 restricted epitopes from the SIV Gag and Pol antigen sequence. Fusion peptides of highly recognized CTL epitopes from SIV Pol and Gag and a strong T-help epitope were shown to be immunogenic and capable of limiting an rVV-SIVGag-Pol challenge. Mamu-A*01/Kb Tg mice provide a model system to study the Mamu-A*01 restricted T-cell response for various infectious diseases which are applicable to a study in RM.

AB - We have developed a murine model expressing the rhesus macaque (RM) Mamu-A*01 MHC allele to characterize immune responses and vaccines based on antigens of importance to human disease processes. Towards that goal, transgenic (Tg) mice expressing chimeric RM (α1 and α2 Mamu-A*01 domains) and murine (α3, transmembrane, and cytoplasmic H-2Kb domains) MHC Class I molecules were derived by transgenesis of the H-2KbDb double MHC Class I knockout strain. After immunization of Mamu-A*01/Kb Tg mice with rVV-SIVGag-Pol, the mice generated CD8+ T-cell IFN-γ responses to several known Mamu-A*01 restricted epitopes from the SIV Gag and Pol antigen sequence. Fusion peptides of highly recognized CTL epitopes from SIV Pol and Gag and a strong T-help epitope were shown to be immunogenic and capable of limiting an rVV-SIVGag-Pol challenge. Mamu-A*01/Kb Tg mice provide a model system to study the Mamu-A*01 restricted T-cell response for various infectious diseases which are applicable to a study in RM.

KW - Cellular immunity

KW - Mamu A01

KW - Peptide vaccine

KW - Poxvirus challenge

KW - SIV

KW - Transgenic mouse model

UR - http://www.scopus.com/inward/record.url?scp=63649096920&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=63649096920&partnerID=8YFLogxK

U2 - 10.1016/j.virol.2009.01.041

DO - 10.1016/j.virol.2009.01.041

M3 - Article

C2 - 19249807

AN - SCOPUS:63649096920

VL - 387

SP - 16

EP - 28

JO - Virology

JF - Virology

SN - 0042-6822

IS - 1

ER -